After-Hours Movers 01/02: (GNMX) (LITE) (AAPL) Lower (more...)

January 2, 2019 6:04 PM

Today's After-Hours Movers

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) 70.4% LOWER; announced that the ASCEND trial, a genomically-guided Phase 2 double-blind, placebo-controlled clinical trial of orally-administered AEVI-001 (100 400 mg BID) in children aged 6 17 with Attention Deficit Hyperactivity Disorder (ADHD) with an mGluR copy number variant (Part A) or without an mGluR copy number variant (Part B), did not achieve statistical significance on the primary endpoint of reduction of ADHD-RS in either Part A or Part B after 6 weeks of treatment with AEVI-001. AEVI-001 was safe and well tolerated. Reported adverse events were minimal and similar across both Part A and Part B treatment groups.

Lumentum Holdings Inc. (NASDAQ: LITE) 8.4% LOWER; Apple suppliers weak following revenue warning.

Apple (NASDAQ: AAPL) 7.2% LOWER; warns for Q1. Sees revenue of approximately $84 billion, versus the consensus of $91.49 billion.

Skyworks Solutions (NASDAQ: SWKS) 5.8% LOWER; Apple suppliers weak following revenue warning

Broadcom (NASDAQ: AVGO) 4.2% LOWER; Apple suppliers weak following revenue warning.

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) 3.3% HIGHER; In a 13G filing on Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), Steven Cohen's Point72 Asset Management, L.P. disclosed a 5.7%, or 4,781,895 share, stake in the company

Netflix (NASDAQ: NFLX) 2.9% LOWER; FAANGs down on Apple warning

Amazon.com (NASDAQ: AMZN) 2.3% LOWER; FAANGs down on Apple warning

Intel (NASDAQ: INTC) 1.7% LOWER; Apple suppliers weak following revenue warning.

Qualcomm (NASDAQ: QCOM) 1.7% LOWER; Apple suppliers weak following revenue warning.

Facebook (NASDAQ: FB) 1.7% LOWER; FAANGs down on Apple warning

Categories

Special Reports

Next Articles